Financials
Financial year 2025
PHARMADES from Stabroek, company number BE0470991418, closed financial year 2025 with a result of € 79,285 after tax. For that financial year PHARMADES recorded a gross margin of € 224,938 and equity of € 1.3 million. Compared with financial year 2024, the result moved from € 73,394 to € 79,285. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 14, 2026.
€ 1.3 million
▲ 6% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 79,285
▲ 8% vs 2024
Profit after tax over the fiscal year.
€ 49,055
▼ 73% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 1.3 million.
People and assets in 2025
1.7
▼ 0.4 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 127,343
▲ 6% vs 2024
€ 74,900 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 1,922
▼ 98% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 56,991
▼ 56% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 19,519
▲ 24% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 393,901 | € 357,463 | € 249,670 | € 224,938 | ▼ 10% |
| Profit after taxes | € 188,496 | € 154,728 | € 73,394 | € 79,285 | ▲ 8% |
| Equity | € 1,024,443 | € 1,179,171 | € 1,252,565 | € 1,331,850 | ▲ 6% |
| Total debts | € 174,195 | € 201,366 | € 143,971 | € 76,510 | ▼ 47% |
| Cash | € 374,505 | € 439,049 | € 184,682 | € 49,055 | ▼ 73% |
| Land & buildings | € 352,751 | € 343,826 | € 334,902 | - | |
| Retained profit | € 949,443 | € 1,104,171 | € 1,177,565 | € 1,256,850 | ▲ 7% |
| Balance sheet total | € 1,198,638 | € 1,380,537 | € 1,396,536 | € 1,408,360 | ▲ 1% |
| Employees (FTE) | 1 | 2.1 | 2.1 | 1.7 | ▼ 0.4 |
Key figures of PHARMADES, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMADES?
What happened at PHARMADES in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 79,285 (▲ 8% vs 2024). filed late Source: NBB ↗
- New establishment in Stabroek. KBO
- Start of the company according to the CBE. KBO
In short
From € 188,496 profit in 2022 to € 79,285 profit in 2025.
Paid € 176,586 in corporate taxes since 2022.
Best year ever: 2022, with € 188,496 profit.
On average € 132,300 of value added per employee in 2025.
Management
Behind PHARMADES is Al Seneid Holding BV. Al Seneid Holding BV is also behind Mato and POLDERSTAD.
Directors
According to the 2025 annual accounts
Establishments
Establishment units
Physical locations of this company
Conservenweg 13d
2940 Stabroek
Conservenweg 13D
2940 Stabroek
Active since 4 September 2000
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0470.991.418
- VAT number
- BE 0470.991.418
- Registered office
- Conservenweg 13d, 2940 Stabroek
- Names & denominations
- PHARMADES
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 18 February 2000
- Peppol
- Active · Active since 21 Oct 2026
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Groothandel in farmaceutische producten